AAP News Vol. 1 No. 2 February 1985, p. 1
© 1985 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Next Article 

Aspirin makers agree to warn public about Reye Syndrome

In the wake of a federal pilot study showing a strong link between aspirin use and Reye Syndrome, the nation's major aspirin manufacturers last month agreed to take several steps warning the public that the drug should not be used to treat children or teenagers with chicken pox or influenza.

The aspirin makers agreed to make label changes and to issue warnings through broadcast public service announcements and store posters. The agreement was reached after nearly two weeks of meetings between the U.S. Food and Drug Administraltion and the Aspirin Foundation of America, a trade organization representing most major aspirin companies.